Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Simpson

Showing results (251-260 of 275) with videos related to

Pageof 28
Sort By:
Journal of Hematology & Oncology|October 15, 2021
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trialsKeshu Zhou, Dehui Zou, Jianfeng Zhou, et al.
Cancer Medicine|September 14, 2023
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysisYuqin Song, Keshu Zhou, Dehui Zou, et al.
Global Change Biology|April 1, 2018
Ozone pollution will compromise efforts to increase global wheat productionGina Mills, Katrina Sharps, David Simpson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2012
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER CohortMaiko Sakamoto, Thomas D Marcotte, Anya Umlauf, et al.
AIDS (London, England)|August 28, 2007
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy studyGiovanni Schifitto, Bradford A Navia, Constantin T Yiannoutsos, et al.
The Lancet. Oncology|February 1, 2017
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trialAndrew D Zelenetz, Jacqueline C Barrientos, Jennifer R Brown, et al.
The New England Journal of Medicine|August 28, 2018
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus, Louise Bowman, Marion Mafham, et al.
The Lancet. Oncology|July 22, 2014
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trialFrits van Rhee, Raymond S Wong, Nikhil Munshi, et al.
Stroke|March 21, 2024
Individual Patient Data Meta-Analysis of Dynamic Cerebral Autoregulation and Functional Outcome After Ischemic StrokeLucy Beishon, Terrie Vasilopoulos, Angela S M Salinet, et al.
Journal of the International Neuropsychological Society : JINS|September 7, 2017
Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United StatesMaría J Marquine, Anne Heaton, Neco Johnson, et al.
Pageof 28

Showing results (251-260 of 275) with videos related to

Sort By:
Pageof 28
Journal of Hematology & Oncology|October 15, 2021
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trialsKeshu Zhou, Dehui Zou, Jianfeng Zhou, et al.
Cancer Medicine|September 14, 2023
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysisYuqin Song, Keshu Zhou, Dehui Zou, et al.
Global Change Biology|April 1, 2018
Ozone pollution will compromise efforts to increase global wheat productionGina Mills, Katrina Sharps, David Simpson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2012
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER CohortMaiko Sakamoto, Thomas D Marcotte, Anya Umlauf, et al.
AIDS (London, England)|August 28, 2007
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy studyGiovanni Schifitto, Bradford A Navia, Constantin T Yiannoutsos, et al.
The Lancet. Oncology|February 1, 2017
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trialAndrew D Zelenetz, Jacqueline C Barrientos, Jennifer R Brown, et al.
The New England Journal of Medicine|August 28, 2018
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus, Louise Bowman, Marion Mafham, et al.
The Lancet. Oncology|July 22, 2014
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trialFrits van Rhee, Raymond S Wong, Nikhil Munshi, et al.
Stroke|March 21, 2024
Individual Patient Data Meta-Analysis of Dynamic Cerebral Autoregulation and Functional Outcome After Ischemic StrokeLucy Beishon, Terrie Vasilopoulos, Angela S M Salinet, et al.
Journal of the International Neuropsychological Society : JINS|September 7, 2017
Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United StatesMaría J Marquine, Anne Heaton, Neco Johnson, et al.
Pageof 28